Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 7Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Carcinoma, Hepatocellular 71Pancreatic Neoplasms 69Colorectal Neoplasms 26Liver Neoplasms 20Neoplasm Metastasis 9Lung Neoplasms 8Melanoma 7Cholangiocarcinoma 6Sarcoma 5Neoplasms 5Colonic Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Gastrointestinal Neoplasms 4Esophageal Neoplasms 4Carcinoma, Renal Cell 4Brain Neoplasms 4Klatskin Tumor 3Urinary Bladder Neoplasms 2Unresectable Locally Recurrent Rectal Cancer 2Thyroid Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Locally Advanced Pancreatic Cancer 2Carcinoma, Non-Small-Cell Lung 2Bile Duct Neoplasms 2Adrenal Gland Neoplasms 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Spinal Cord Compression 1

Interventions

pembrolizumab 50Cyclophosphamide 25Carboplatin 25Gemcitabine 20Cisplatin 19fludarabine 18Nivolumab 17Paclitaxel 16Bevacizumab 15Specimen Handling 14Fluorouracil 11Magnetic Resonance Spectroscopy 10aldesleukin 9Oxaliplatin 9Irinotecan 9Docetaxel 9Biopsy 9olaparib 8Trastuzumab 8durvalumab 7atezolizumab 7Hyperthermic Intraperitoneal Chemotherapy 7Albumin-Bound Paclitaxel 7Taxes 6Leucovorin 6Ipilimumab 6Interleukin-2 6Cetuximab 6Capecitabine 6130-nm albumin-bound paclitaxel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Radiosurgery × Gastrointestinal × Clear all
NCT06940921 2025-04-27

SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases

First Affiliated Hospital of Chongqing Medical University

Phase 1/2 Active not recruiting
26 enrolled
GastrointestinalGynecologic

Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡